We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,213
Reduced
6,341
Closed
1,909

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.07%
2 Financials 2.32%
3 Consumer Discretionary 2.2%
4 Healthcare 2.2%
5 Communication Services 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCNX
13026
Scienture Holdings
SCNX
$15.7M
$60K ﹤0.01%
+1,717
New +$95.2K
DXYN
13027
CALL
DELISTED
Dixie Group Inc
DXYN
$60K ﹤0.01%
10,400
-9,300
-47% -$50.6K
SPECW
13028
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$60K ﹤0.01%
+136,176
New +$65K
TCON
13029
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$60K ﹤0.01%
1,089
-734
-40% -$46.8K
HHLA.WS
13030
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$60K ﹤0.01%
107,425
+17
+0% +$9
OTMO
13031
PUT
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$60K ﹤0.01%
980
-107
-10% -$6.77K
IPVIW
13032
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$60K ﹤0.01%
75,000
CTIC
13033
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$60K ﹤0.01%
+24,300
New +$59.5K
ADTX
13034
DELISTED
ADITXT INC
ADTX
0
EQ icon
13035
Equillium
EQ
$139M
$59K ﹤0.01%
15,638
+4,729
+43% +$25.6K
OPTT icon
13036
Ocean Power Technologies
OPTT
$48.6M
$59K ﹤0.01%
39,947
+8,218
+26% +$16K
VVOS icon
13037
Vivos Therapeutics
VVOS
$5.84M
$59K ﹤0.01%
1,043
-2,122
-67% -$171K
WYY icon
13038
WidePoint Corp
WYY
$103M
$59K ﹤0.01%
+14,993
New +$71K
BTTX
13039
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$59K ﹤0.01%
+12,713
New +$104K
MARK
13040
PUT
DELISTED
Remark Holdings, Inc.
MARK
$59K ﹤0.01%
5,990
-1,990
-25% -$25.9K
HCIIW
13041
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$59K ﹤0.01%
88,003
-53,821
-38% -$46.9K
EMWP
13042
DELISTED
Eros Media World PLC
EMWP
$59K ﹤0.01%
12,207
+2,258
+23% +$25.8K
NAVB
13043
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$59K ﹤0.01%
58,562
+16,425
+39% +$23.1K
ACIU icon
13044
PUT
AC Immune
ACIU
$226M
$58K ﹤0.01%
11,800
-14,200
-55% -$82.5K
CNSP icon
13045
CNS Pharmaceuticals
CNSP
$8.46M
0
DERM icon
13046
Journey Medical
DERM
$178M
$58K ﹤0.01%
+10,761
New +$77.9K
EMX
13047
DELISTED
EMX Royalty
EMX
$58K ﹤0.01%
25,372
+11,131
+78% +$28.5K
LYRA
13048
DELISTED
LYRA THERAPEUTICS INC
LYRA
$58K ﹤0.01%
+265
New +$85.1K
OMEX icon
13049
Odyssey Marine Exploration
OMEX
$38.6M
$58K ﹤0.01%
+11,186
New +$67.8K
TTI icon
13050
CALL
TETRA Technologies
TTI
$1.15B
$58K ﹤0.01%
20,300
-30,000
-60% -$92.5K

Similar funds

Citadel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Citadel Advisors held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $30B in Q4 2021, closing 1,909 positions and reducing 6,341 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Citadel Advisors's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Citadel Advisors added most to Amazon in Q4 2021, an estimated $802M increase.
  • Citadel Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Citadel Advisors fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Citadel Advisors's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Citadel Advisors opened 1,894 new positions and closed 1,909 in Q4 2021.
  • Citadel Advisors's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.